(NP (NP Glucocorticoid/NN receptors/NNS) (PP in/IN (NP (NP mononuclear/JJ cells/NNS) (PP of/IN (NP (NP patients/NNS) (PP with/IN (NP sepsis/NN)))))) ./.)
(S (NP-SBJ-69 (NP (NP Glucocorticoid/NN receptor/NN) (PRN -LRB-/-LRB- (NP GR/NN) -RRB-/-RRB-)) hormone-binding/NN activity/NN) (VP was/VBD (VP studied/VBN (NP *-69/-NONE-) (PP by/IN (NP a/DT whole-cell/JJ method/NN)) (PP in/IN (NP (NP (NP mononuclear/JJ cells/NNS) (PRN -LRB-/-LRB- (NP MNC/NN) -RRB-/-RRB-)) (PP from/IN (NP (NP peripheral/JJ blood/NN) (PP of/IN (NP 7/CD patients/NNS)))))) (PP-TMP during/IN (NP (NP the/DT hemodynamic/JJ compensatory/JJ phase/NN) (PP of/IN (NP sepsis/NN)))))) ./.)
(S (NP-SBJ 4/CD patients/NNS) (VP were/VBD (VP receiving/VBG (NP (NP dopamine/NN) ,/, (SBAR (WHNP-70 which/WDT) (S (NP-SBJ *T*-70/-NONE-) (VP did/VBD not/RB (VP affect/VB (NP the/DT GR/NN count/NN)))))))) ./.)
(S (NP-SBJ (NP The/DT patients/NNS '/POS) plasma/NN cortisol/NN concentrations/NNS) (VP were/VBD (ADJP-PRD-COOD (ADJP normal/JJ) or/CC (ADJP slightly/RB elevated/JJ))) ./.)
(S (PP Despite/IN (NP a/DT wide/JJ range/NN)) ,/, (NP-SBJ (NP the/DT mean/NN GR/NN (NP-COOD (NP count/NN) and/CC (NP affinity/NN))) (PP in/IN (NP (NP MNC/NN) (PP from/IN (NP septic/JJ patients/NNS))))) (VP did/VBD not/RB (VP differ/VB (PP from/IN (NP (NP those/DT) (PP in/IN (NP normal/JJ controls/NNS)))) ,/, (S (NP-SBJ */-NONE-) (VP suggesting/VBG (SBAR that/IN (S (NP-SBJ glucocorticoids/NNS) (VP could/MD (VP (ADVP still/RB) (VP be/VB (ADJP-PRD effective/JJ) (PP in/IN (NP (NP the/DT hemodynamic/JJ compensatory/JJ phase/NN) (PP of/IN (NP sepsis/NN))))))))))))) ./.)
